-
Trevi Therapeutics (NASDAQ:TRVI) Earns Buy Rating from D. Boral Capital
ソース: Buzz FX / 24 2 2025 07:31:19 America/Chicago
Trevi Therapeutics (NASDAQ:TRVI) Earns Buy Rating from D. Boral Capital Written by MarketBeat February 24, 2025 Share Link copied to clipboard. Trevi Therapeutics ( NASDAQ:TRVI - Get Free Report ) 's stock had its "buy" rating reiterated by
Read more...